Creative Medical Technology Holdings, Inc.
General ticker "CELZ" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $5.6M (TTM average)
Creative Medical Technology Holdings, Inc. follows the US Stock Market performance with the rate: 26.4%.
Estimated limits based on current volatility of 4.4%: low 2.11$, high 2.39$
Factors to consider:
- Total employees count: 7 as of 2009
- Company does not operate outside North America (retrieved using AI)
- Top business risk factors: Liquidity and credit risks, Third-party risks, IT system disruptions, Geopolitical risks, Key management loss
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [1.00$, 3.40$]
- 2025-12-31 to 2026-12-31 estimated range: [0.56$, 1.95$]
Financial Metrics affecting the CELZ estimates:
- Positive: with PPE of -0.6 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -162.60 <= 0.33
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Positive: Shareholder equity ratio, % of 95.09 > 63.39
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Positive: Investing cash flow per share per price, % of 193.86 > -0.66
- Negative: negative Industry operating cash flow (median)
Short-term CELZ quotes
Long-term CELZ plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.09MM | $0.01MM | $0.01MM |
| Operating Expenses | $10.33MM | $5.63MM | $5.75MM |
| Operating Income | $-10.24MM | $-5.62MM | $-5.74MM |
| Non-Operating Income | $0.10MM | $0.33MM | $0.25MM |
| R&D Expense | $6.27MM | $1.97MM | $2.40MM |
| Income(Loss) | $-10.14MM | $-5.29MM | $-5.49MM |
| Profit(Loss)* | $-10.14MM | $-5.29MM | $-5.49MM |
| Stockholders Equity | $15.86MM | $10.34MM | $6.34MM |
| Inventory | $0.01MM | $0.01MM | $0.00MM |
| Assets | $19.19MM | $10.72MM | $6.67MM |
| Operating Cash Flow | $-7.80MM | $-8.03MM | $-5.30MM |
| Capital expenditure | $0.00MM | $0.10MM | $0.00MM |
| Investing Cash Flow | $-10.08MM | $3.45MM | $6.32MM |
| Financing Cash Flow | $15.47MM | $-0.27MM | $1.45MM |
| Earnings Per Share** | $-9.28 | $-3.76 | $-3.71 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.